Institutionen för medicinska vetenskaper

Publikationer

PubMed Torbjörn Linde

PubMed Bengt Fellström

PubMed Björn Wikström

Utvalda publikationer

1. Bengt Fellstrӧm, Rosanna Coppo, John Feehally, Jürgen Floege, Johan W. de Fijter, Alan G. Jardine, Petri Koskinen, Fernanda Ortiz, Francesco Locatelli, Lucia Del Vecchio, Gerd Hetzel, Bart D. Maes, Alex Mercer, Manuel Praga, Søren S. Sørensen, Vladimir Tesar.   Effects of a novel targeted release formulation of budesonide in patients with IgA nephropathy at risk of end stage renal disease: The NEFIGAN Trial. The Lancet, 2016 ( accepted)

2. Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E. Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study. Am J Transplant. 2016 Aug 2.

3. Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG. Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study. Nephrol Dial Transplant. 2016 Oct 17.

4. Staplin N, Haynes R, Herrington WG, Reith C, Cass A, Fellström B, Jiang L, Kasiske BL, Krane V, Levin A, Walker R, Wanner C, Wheeler DC, Landray MJ, Baigent C, Emberson J; SHARP Collaborative Group.. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016 Sep;68(3):371-80.

5. Stenberg J, Lindberg M, Furuland H. Clinical praxis for assessment of dry weight in Sweden and Denmark: A mixed-methods study. Hemodial Int. 2015 Aug 11

6. SHARP Collaborative Group : Haynes, Richard; Lewis, David,Emberson, Jonathan; Reith, Christina; Agodoa, Lawrence; Cass, Alan; Craig, Jonathan; De Zeeuw, Dick; Feldt-Rasmussen, Bo; Fellstrom, Bengt; Levin, Adeera; Wheeler, David; Walker, Robert; Herrington, William; Baigent, Colin;. Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc Nephrol, 2014 ; 25 : 1825-1833 

7. The SHARP Collaborative Group : Haynes, Richard; Lewis, David,Emberson, Jonathan; Reith, Christina; Agodoa, Lawrence; Cass, Alan; Craig, Jonathan; De Zeeuw, Dick; Feldt-Rasmussen, Bo; Fellstrom, Bengt; Levin, Adeera; Wheeler, David; Walker, Robert; Herrington, William; Baigent, Colin. Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP) . Am J Kidney Dis 2014 ; 64: 40-48  

 8. Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, Sterner G, Bäck SE for the SBU GFR review group. Measuring Glomerular Filtration Rate. A Systematic Review. Am J Kidney Dis 2014 Sep;64(3):411-24.

9. Soveri I, Snyder J, Holdaas H, Holme I, Jardine AG, L´Italien G, Fellström B. The external validation of the cardiovascular risk equation for renal transplant recipients. Applications to BENEFIT and BENEFIT-EXT Trials. Transplantation. Transplantation. 2013 Jan 15;95(1):142-147.

10. Westerberg PA, Tivesten Å, Karlsson MK, Mellström D, Orwoll E, Ohlsson C, Larsson TE, Linde T, Ljunggren Ö. Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs). BMC Nephrol. 2013 Apr 15;14:85.

11. Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B. A cardiovascular risk calculator for renal transplant recipients. Transplantation. 2012 Jul 15;94(1):57-62.

12. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H. Inflammation-associated graft loss in renal transplant recipients. Nephrol Dial Transplant. 2011 Nov;26(11):3756-61.

13. Smerud HK, Bárány P, Lindström K, Fernström A, Sandell A, Påhlsson P, Fellström B. New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria. Nephrol Dial Transplant. 2011 Oct;26(10):3237-42.

14. Alan G Jardine, Robert S Gaston, Bengt Fellstrom, Hallvard Holdaas. Prevention of cardiovascular disease and new-onset diabetes in solid-organ transplantation  . Lancet, 2011; 378:1419-1427.

15. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy Z, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Haas M, Grobbee R, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Strony J, Musliner T, Grimm R, Pedersen T, Tobert J, Bray C, Knott C, Collins R, on behalf of the SHARP Investigators. Effects of lowering LDL-cholesterol with ezetimibe/simvastatin in patients with chronic kidney disease: the Study of Heart and Renal Protection (SHARP). Lancet 2011 Jun 25;377(9784):2181-92.

16. Fellström, Jardine, Schmieder, Holdaas, Tesar…Zannad et al . Rosuvastatin and Cardiovascuular Events in Patients Undergoing Hemodialysis. New Engl J Med 2009; 360:1395-1407

17. Holdaas H, Fellström B, Jardine A et al.  Effects of Fluvastatin on Cardiac Outcomes in Renal Transplant Recipients : A Randomized Placebo Controlled Trial. Lancet 2003; 61:(9374):2024-31.